Alzheimer’s drugs eyed as next big obesity-like opportunity
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
Alzheimer’s Drugs Eyed by Investors Seeking Obesity-Like Gains
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
Could Alzheimer’s treatment drugs be the next big investor opportunity after obesity pills?
The search for effective Alzheimer’s treatments is emerging as a promising market, capturing the attention of major ...
BioSpace4dOpinion
Opinion: The Cocktail Recipe That Will Cure Alzheimer’s
Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...
Neurology Advisor11d
Reduce Risk of Dementia by Combining Cardiovascular Disease Drug Classes
Researchers found that combining cardiovascular disease drug classes, particularly antihypertensives, can reduce risk of dementia.
STAT11d
Axsome to send Alzheimer’s disease drug to FDA, despite mixed Phase 3 results
Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two ...
Ars Technica29d
Weight loss drugs may also treat addiction, Alzheimer’s, and heart disease
One of the most intriguing is a late-stage trial of semaglutide in Alzheimer’s patients ... with the drugs available at a large discount to the list price. Side-effects including nausea ...
朝日新聞社1y
Alzheimer’s drug lecanemab set to soon be approved for use in Japan
Conventional dementia medications are designed to relieve symptoms by activating certain operations in the nervous system. Lecanemab, on the other hand, is designed to slow the development of ...